A detailed history of Commerce Bank transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Commerce Bank holds 2,016 shares of SRPT stock, worth $219,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,016
Previous 1,742 15.73%
Holding current value
$219,965
Previous $275,000 8.73%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$124.33 - $156.75 $34,066 - $42,949
274 Added 15.73%
2,016 $251,000
Q2 2024

Aug 12, 2024

BUY
$113.33 - $163.85 $6,459 - $9,339
57 Added 3.38%
1,742 $275,000
Q1 2024

May 03, 2024

BUY
$93.7 - $141.53 $157,884 - $238,478
1,685 New
1,685 $218,000
Q3 2023

Nov 13, 2023

BUY
$102.5 - $123.59 $14,657 - $17,673
143 Added 7.94%
1,943 $235,000
Q2 2023

Aug 08, 2023

BUY
$106.4 - $157.19 $25,110 - $37,096
236 Added 15.09%
1,800 $206,000
Q1 2023

May 04, 2023

BUY
$117.53 - $155.99 $183,816 - $243,968
1,564 New
1,564 $215,000
Q2 2022

Aug 12, 2022

SELL
$62.69 - $88.44 $168,824 - $238,168
-2,693 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$63.15 - $90.42 $22,797 - $32,641
361 Added 15.48%
2,693 $210,000
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $180,216 - $231,847
2,332 New
2,332 $210,000
Q3 2021

Nov 09, 2021

SELL
$65.97 - $92.48 $230,829 - $323,587
-3,499 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$69.38 - $86.75 $16,789 - $20,993
242 Added 7.43%
3,499 $272,000
Q1 2021

May 05, 2021

BUY
$72.25 - $168.95 $16,617 - $38,858
230 Added 7.6%
3,257 $243,000
Q4 2020

Feb 09, 2021

SELL
$125.56 - $178.74 $20,591 - $29,313
-164 Reduced 5.14%
3,027 $516,000
Q3 2020

Nov 06, 2020

BUY
$127.12 - $172.34 $889 - $1,206
7 Added 0.22%
3,191 $448,000
Q2 2020

Aug 07, 2020

SELL
$93.0 - $171.7 $4,464 - $8,241
-48 Reduced 1.49%
3,184 $511,000
Q1 2020

May 08, 2020

BUY
$82.38 - $131.64 $266,252 - $425,460
3,232 New
3,232 $316,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.55B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.